Parkinson's disease (PD) poses challenges in diagnosis and monitoring due to its progressive nature and complex symptoms. This study introduces a novel approach utilizing surface electromyography (sEMG) to objectively assess PD severity, focusing on the biceps brachii muscle. Initial analysis of sEMG data from five PD patients and five healthy controls revealed significant neuromuscular differences. A traditional Support Vector Machine (SVM) model achieved up to 83% accuracy, while enhancements with a Graph Convolutional Network-Support Vector Machine (GCN-SVM) model increased accuracy to 92%. Despite the preliminary nature of these results, the study outlines a detailed experimental methodology for future research with larger cohorts to validate these findings and integrate the approach into clinical practice. The proposed approach holds promise for advancing PD severity assessment and improving patient care in Parkinson's disease management.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Surface EMG Profiling in Parkinson's Disease: Advancing Severity Assessment with GCN-SVM

  • Daniel Cieślak,
  • Barbara Szyca,
  • Michalina Razik,
  • Liwia Florkiewicz,
  • Anna Prus,
  • Hubert Lis,
  • Kinga Grzęda,
  • Weronika Bajko,
  • Helena Kamieniecka,
  • Weronika Matwiejuk,
  • Inga Rozumowicz,
  • Wiktoria Ziembakowska,
  • Mariusz Kaczmarek

摘要

Parkinson's disease (PD) poses challenges in diagnosis and monitoring due to its progressive nature and complex symptoms. This study introduces a novel approach utilizing surface electromyography (sEMG) to objectively assess PD severity, focusing on the biceps brachii muscle. Initial analysis of sEMG data from five PD patients and five healthy controls revealed significant neuromuscular differences. A traditional Support Vector Machine (SVM) model achieved up to 83% accuracy, while enhancements with a Graph Convolutional Network-Support Vector Machine (GCN-SVM) model increased accuracy to 92%. Despite the preliminary nature of these results, the study outlines a detailed experimental methodology for future research with larger cohorts to validate these findings and integrate the approach into clinical practice. The proposed approach holds promise for advancing PD severity assessment and improving patient care in Parkinson's disease management.